95 related articles for article (PubMed ID: 32932287)
1. Effectiveness of the cervical cancer prevention programme: a case-control mortality audit in Lithuania.
Everatt R; Kuzmickienė I; Intaitė B; Anttila A
Eur J Cancer Prev; 2020 Nov; 29(6):504-510. PubMed ID: 32932287
[TBL] [Abstract][Full Text] [Related]
2. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program.
Wang J; Elfström KM; Andrae B; Nordqvist Kleppe S; Ploner A; Lei J; Dillner J; Sundström K; Sparén P
Int J Cancer; 2020 Mar; 146(5):1230-1240. PubMed ID: 31107987
[TBL] [Abstract][Full Text] [Related]
4. Mortality audit of the Finnish cervical cancer screening program.
Lönnberg S; Nieminen P; Luostarinen T; Anttila A
Int J Cancer; 2013 May; 132(9):2134-40. PubMed ID: 22987437
[TBL] [Abstract][Full Text] [Related]
5. Age-specific effectiveness of the Finnish cervical cancer screening programme.
Lönnberg S; Anttila A; Luostarinen T; Nieminen P
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1354-61. PubMed ID: 22665576
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic and lifestyle determinants of non-attendance for cervical cancer screening in Lithuania, 2006-2014.
Petkeviciene J; Ivanauskiene R; Klumbiene J
Public Health; 2018 Mar; 156():79-86. PubMed ID: 29408192
[TBL] [Abstract][Full Text] [Related]
7. Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and Romania.
Arbyn M; Antoine J; Valerianova Z; Mägi M; Stengrevics A; Smailyte G; Suteu O; Micheli A
Tumori; 2010; 96(4):517-23. PubMed ID: 20968129
[TBL] [Abstract][Full Text] [Related]
8. Organised Versus Opportunistic Cervical Cancer Screening in Urban and Rural Regions of Lithuania.
Paulauskiene J; Ivanauskiene R; Skrodeniene E; Petkeviciene J
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31500116
[No Abstract] [Full Text] [Related]
9. Trends in cervical cancer mortality rates in Lithuania, 1987-2016.
Everatt R; Intaitė B
Cancer Epidemiol; 2018 Dec; 57():85-89. PubMed ID: 30347336
[TBL] [Abstract][Full Text] [Related]
10. Association between cervical screening and prevention of invasive cervical cancer in Ontario: a population-based case-control study.
Vicus D; Sutradhar R; Lu Y; Kupets R; Paszat L;
Int J Gynecol Cancer; 2015 Jan; 25(1):106-11. PubMed ID: 25377725
[TBL] [Abstract][Full Text] [Related]
11. Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study.
Landy R; Pesola F; Castañón A; Sasieni P
Br J Cancer; 2016 Oct; 115(9):1140-1146. PubMed ID: 27632376
[TBL] [Abstract][Full Text] [Related]
12. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review.
Jansen EEL; Zielonke N; Gini A; Anttila A; Segnan N; Vokó Z; Ivanuš U; McKee M; de Koning HJ; de Kok IMCM;
Eur J Cancer; 2020 Mar; 127():207-223. PubMed ID: 31980322
[TBL] [Abstract][Full Text] [Related]
13. [Cervical cancer: recent trends of incidence and mortality in Lithuania].
Aleknaviciene B; Smailyte G; Elaawar B; Kurtinaitis J
Medicina (Kaunas); 2002; 38(2):223-30. PubMed ID: 12474744
[TBL] [Abstract][Full Text] [Related]
14. The Cost-Effectiveness Analysis of Cervical Cancer Screening Using a Systematic Invitation System in Lithuania.
Paulauskiene J; Stelemekas M; Ivanauskiene R; Petkeviciene J
Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31835649
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening in Korea: report on the National Cancer Screening Programme in 2008.
Mun JY; Han MA; Lee HY; Jun JK; Choi KS; Park EC
Asian Pac J Cancer Prev; 2011; 12(8):1961-4. PubMed ID: 22292633
[TBL] [Abstract][Full Text] [Related]
16. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Kitchener HC; Gittins M; Rivero-Arias O; Tsiachristas A; Cruickshank M; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
Health Technol Assess; 2016 Sep; 20(68):1-138. PubMed ID: 27632816
[TBL] [Abstract][Full Text] [Related]
17. Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study.
Broberg G; Wang J; Östberg AL; Adolfsson A; Nemes S; Sparén P; Strander B
PLoS One; 2018; 13(1):e0190171. PubMed ID: 29320536
[TBL] [Abstract][Full Text] [Related]
18. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
19. The association between cervical cancer screening and mortality from cervical cancer: a population based case-control study.
Vicus D; Sutradhar R; Lu Y; Elit L; Kupets R; Paszat L;
Gynecol Oncol; 2014 May; 133(2):167-71. PubMed ID: 24589414
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Visual Inspection with Acetic Acid (VIA) Screening on Cervical Cancer Mortality and Incidence - A Systematic Review and Meta-Analysis.
Lohiya A; Daniel RA; Kumar D; Varghese C; Rath RS; S A R; Nongkynrih B
Asian Pac J Cancer Prev; 2022 Feb; 23(2):399-407. PubMed ID: 35225450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
